Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

The effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling and hepatic inflammation.

Gai Z, Visentin M, Gui T, Zhao L, Thasler WE, Hausler S, Hartling I, Cremonesi A, Hiller C, Kullak-Ublick GA.

Mol Pharmacol. 2018 May 9. pii: mol.117.111047. doi: 10.1124/mol.117.111047. [Epub ahead of print]

2.

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy.

Bedini N, Cicchetti A, Palorini F, Magnani T, Zuco V, Pennati M, Campi E, Allavena P, Pesce S, Villa S, Avuzzi B, Morlino S, Visentin ME, Zaffaroni N, Rancati T, Valdagni R.

Dis Markers. 2018 Feb 25;2018:9128128. doi: 10.1155/2018/9128128. eCollection 2018.

3.

Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).

Visentin M, Gai Z, Torozi A, Hiller C, Kullak-Ublick GA.

Drug Metab Dispos. 2017 Dec;45(12):1240-1244. doi: 10.1124/dmd.117.077248. Epub 2017 Oct 6.

PMID:
28986476
4.

Drug-induced bile duct injury.

Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA.

Biochim Biophys Acta. 2018 Apr;1864(4 Pt B):1498-1506. doi: 10.1016/j.bbadis.2017.08.033. Epub 2017 Sep 4. Review.

PMID:
28882625
5.

Results of an interlaboratory comparison of analytical methods for quantification of anhydrosugars and biosugars in atmospheric aerosol.

Chiara Pietrogrande M, Barbaro E, Bove MC, Clauser G, Colombi C, Corbella L, Cuccia E, Dalla Torre S, Decesari S, Fermo P, Gambaro A, Gianelle V, Ielpo P, Larcher R, Lazzeri P, Massabò D, Melchionna G, Nardin T, Paglione M, Perrino C, Prati P, Visentin M, Zanca N, Zangrando R.

Chemosphere. 2017 Oct;184:269-277. doi: 10.1016/j.chemosphere.2017.05.131. Epub 2017 May 26.

6.

Optimization of an ultrasound-assisted derivatization for GC/MS analysis of oxygenated organic species in atmospheric aerosol.

Pietrogrande MC, Manarini F, Quintana JB, Rodil R, Villaverde-de-Sáa E, Visentin M.

Anal Bioanal Chem. 2017 Jul;409(17):4279-4291. doi: 10.1007/s00216-017-0379-6. Epub 2017 May 18.

PMID:
28516280
7.

Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.

Visentin M, van Rosmalen BV, Hiller C, Bieze M, Hofstetter L, Verheij J, Kullak-Ublick GA, Koepsell H, Phoa SS, Tamai I, Bennink RJ, van Gulik TM, Stieger B.

Drug Metab Dispos. 2017 Feb;45(2):166-173. doi: 10.1124/dmd.116.072371. Epub 2016 Nov 30.

8.

Contribution of occupational factors to the incidence and persistence of chronic low back pain among workers: results from the longitudinal VISAT study.

Esquirol Y, Niezborala M, Visentin M, Leguevel A, Gonzalez I, Marquié JC.

Occup Environ Med. 2017 Mar;74(4):243-251. doi: 10.1136/oemed-2015-103443. Epub 2016 Sep 26.

PMID:
27672181
9.

Urban PM2.5 oxidative potential: Importance of chemical species and comparison of two spectrophotometric cell-free assays.

Visentin M, Pagnoni A, Sarti E, Pietrogrande MC.

Environ Pollut. 2016 Dec;219:72-79. doi: 10.1016/j.envpol.2016.09.047. Epub 2016 Sep 20.

PMID:
27661730
10.

Direct observation of aqueous secondary organic aerosol from biomass-burning emissions.

Gilardoni S, Massoli P, Paglione M, Giulianelli L, Carbone C, Rinaldi M, Decesari S, Sandrini S, Costabile F, Gobbi GP, Pietrogrande MC, Visentin M, Scotto F, Fuzzi S, Facchini MC.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10013-8. doi: 10.1073/pnas.1602212113. Epub 2016 Aug 22.

11.

Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.

Gai Z, Visentin M, Hiller C, Krajnc E, Li T, Zhen J, Kullak-Ublick GA.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5573-80. doi: 10.1128/AAC.00907-16. Print 2016 Sep.

12.

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.

Langsteger W, Rezaee A, Loidl W, Geinitz HS, Fitz F, Steinmair M, Broinger G, Pallwien-Prettner L, Beheshti M, Imamovic L, Beheshti M, Rendl G, Hackl D, Tsybrovsky O, Steinmair M, Emmanuel K, Moinfar F, Pirich C, Langsteger W, Bytyqi A, Karanikas G, Mayerhöfer M, Koperek O, Niederle B, Hartenbach M, Beyer T, Herrmann K, Czernin J, Rausch I, Rust P, DiFranco MD, Lassen M, Stadlbauer A, Mayerhöfer ME, Hartenbach M, Hacker M, Beyer T, Binzel K, Magnussen R, Wei W, Knopp MU, Flanigan DC, Kaeding C, Knopp MV, Leisser A, Nejabat M, Hartenbach M, Kramer G, Krainer M, Hacker M, Haug A, Lehnert W, Schmidt K, Kimiaei S, Bronzel M, Kluge A, Wright CL, Binzel K, Zhang J, Wuthrick E, Maniawski P, Knopp MV, Blaickner M, Rados E, Huber A, Dulovits M, Kulkarni H, Wiessalla S, Schuchardt C, Baum RP, Knäusl B, Georg D, Bauer M, Wulkersdorfer B, Wadsak W, Philippe C, Haslacher H, Zeitlinger M, Langer O, Bauer M, Feldmann M, Karch R, Wadsak W, Zeitlinger M, Koepp MJ, Asselin MC, Pataraia E, Langer O, Zeilinger M, Philippe C, Dumanic M, Pichler F, Pilz J, Hacker M, Wadsak W, Mitterhauser M, Nics L, Steiner B, Hacker M, Mitterhauser M, Wadsak W, Traxl A, Wanek T, Kryeziu K, Mairinger S, Stanek J, Berger W, Kuntner C, Langer O, Mairinger S, Wanek T, Traxl A, Krohn M, Stanek J, Filip T, Sauberer M, Kuntner C, Pahnke J, Langer O, Svatunek D, Denk C, Wilkovitsch M, Wanek T, Filip T, Kuntner-Hannes C, Fröhlich J, Mikula H, Denk C, Svatunek D, Wanek T, Mairinger S, Stanek J, Filip T, Fröhlich J, Mikula H, Kuntner-Hannes C, Balber T, Singer J, Fazekas J, Rami-Mark C, Berroterán-Infante N, Jensen-Jarolim E, Wadsak W, Hacker M, Viernstein H, Mitterhauser M, Denk C, Svatunek D, Sohr B, Mikula H, Fröhlich J, Wanek T, Kuntner-Hannes C, Filip T, Pfaff S, Philippe C, Mitterhauser M, Hartenbach M, Hacker M, Wadsak W, Wanek T, Halilbasic E, Visentin M, Mairinger S, Stieger B, Kuntner C, Trauner M, Langer O, Lam P, Aistleitner M, Eichinger R, Artner C, Eidherr H, Vraka C, Haug A, Mitterhauser M, Nics L, Hartenbach M, Hacker M, Wadsak W, Kvaternik H, Müller R, Hausberger D, Zink C, Aigner RM, Cossío U, Asensio M, Montes A, Akhtar S, Te Welscher Y, van Nostrum R, Gómez-Vallejo V, Llop J, VandeVyver F, Barclay T, Lippens N, Troch M, Hehenwarter L, Egger B, Holzmannhofer J, Rodrigues-Radischat M, Pirich C, Pötsch N, Rausch I, Wilhelm D, Weber M, Furtner J, Karanikas G, Wöhrer A, Mitterhauser M, Hacker M, Traub-Weidinger T, Cassou-Mounat T, Balogova S, Nataf V, Calzada M, Huchet V, Kerrou K, Devaux JY, Mohty M, Garderet L, Talbot JN, Stanzel S, Pregartner G, Schwarz T, Bjelic-Radisic V, Liegl-Atzwanger B, Aigner R, Stanzel S, Quehenberger F, Aigner RM, Marković AK, Janković M, Jerković VM, Paskaš M, Pupić G, Džodić R, Popović D, Fornito MC, Familiari D, Koranda P, Polzerová H, Metelková I, Henzlová L, Formánek R, Buriánková E, Kamínek M, Thomson WH, Lewis C, Thomson WH, O'Brien J, James G, Notghi A, Huber H, Stelzmüller I, Wunn R, Mandl M, Fellner F, Lamprecht B, Gabriel M, Fornito MC, Leonardi G, Thomson WH, O'Brien J, James G, Hudzietzová J, Sabol J, Fülöp M.

EJNMMI Res. 2016 Apr;6(Suppl 1):32. doi: 10.1186/s13550-016-0168-9. Epub 2016 Apr 18.

13.

Final design of the beam source for the MITICA injector.

Marcuzzi D, Agostinetti P, Dalla Palma M, De Muri M, Chitarin G, Gambetta G, Marconato N, Pasqualotto R, Pavei M, Pilan N, Rizzolo A, Serianni G, Toigo V, Trevisan L, Visentin M, Zaccaria P, Zaupa M, Boilson D, Graceffa J, Hemsworth RS, Choi CH, Marti M, Roux K, Singh MJ, Masiello A, Froeschle M, Heinemann B, Nocentini R, Riedl R, Tobari H, de Esch HP, Muvvala VN.

Rev Sci Instrum. 2016 Feb;87(2):02B309. doi: 10.1063/1.4932615.

PMID:
26932037
14.

Characteristics and major sources of carbonaceous aerosols in PM2.5 in Emilia Romagna Region (Northern Italy) from four-year observations.

Pietrogrande MC, Bacco D, Ferrari S, Ricciardelli I, Scotto F, Trentini A, Visentin M.

Sci Total Environ. 2016 May 15;553:172-183. doi: 10.1016/j.scitotenv.2016.02.074. Epub 2016 Feb 27.

PMID:
26925729
15.

Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice.

Wanek T, Halilbasic E, Visentin M, Mairinger S, Römermann K, Stieger B, Kuntner C, Müller M, Langer O, Trauner M.

J Pharm Sci. 2016 Jan;105(1):106-12. doi: 10.1016/j.xphs.2015.11.014. Epub 2016 Jan 13.

PMID:
26852845
16.

Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.

Visentin M, Stieger B, Merz M, Kullak-Ublick GA.

J Pharmacol Exp Ther. 2015 Nov;355(2):145-51. doi: 10.1124/jpet.115.227546. Epub 2015 Sep 1.

17.

Effectiveness of opioid analgesics in chronic noncancer pain.

Ferrari R, Zanolin ME, Duse G, Visentin M.

Pain Pract. 2015 Mar;15(3):272-8.

PMID:
25914912
18.

Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.

Zhao R, Visentin M, Goldman ID.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1163-73. doi: 10.1007/s00280-015-2733-8. Epub 2015 Apr 7.

19.

Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).

Visentin M, Unal ES, Najmi M, Fiser A, Zhao R, Goldman ID.

Am J Physiol Cell Physiol. 2015 Apr 15;308(8):C631-41. doi: 10.1152/ajpcell.00238.2014. Epub 2015 Jan 21.

20.

Risk assessment of opioid misuse in italian patients with chronic noncancer pain.

Ferrari R, Duse G, Capraro M, Visentin M.

Pain Res Treat. 2014;2014:584986. doi: 10.1155/2014/584986. Epub 2014 Aug 10.

21.

Determination of polar organic compounds in atmospheric aerosols by gas chromatography with ion trap tandem mass spectrometry.

Visentin M, Pietrogrande MC.

J Sep Sci. 2014 Jul;37(13):1561-9. doi: 10.1002/jssc.201301332. Epub 2014 May 14.

PMID:
24723391
22.

The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro.

Visentin M, Unal ES, Goldman ID.

Cancer Chemother Pharmacol. 2014 May;73(5):1055-62. doi: 10.1007/s00280-014-2441-9. Epub 2014 Mar 29.

23.

The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: a before-after cluster phase II trial.

Ripamonti CI, Prandi C, Costantini M, Perfetti E, Pellegrini F, Visentin M, Garrino L, De Luca A, Pessi MA, Peruselli C.

BMC Palliat Care. 2014 Mar 29;13(1):15. doi: 10.1186/1472-684X-13-15.

24.

The intestinal absorption of folates.

Visentin M, Diop-Bove N, Zhao R, Goldman ID.

Annu Rev Physiol. 2014;76:251-74. doi: 10.1146/annurev-physiol-020911-153251. Review.

25.

The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.

Visentin M, Unal ES, Zhao R, Goldman ID.

Cancer Chemother Pharmacol. 2013 Sep;72(3):597-606. doi: 10.1007/s00280-013-2231-9. Epub 2013 Jul 24.

26.

A new Italian questionnaire to assess caregivers of cancer patients' satisfaction with palliative care: multicenter validation of the post mortem questionnaire-short form.

Partinico M, Corà A, Ghisi M, Ouimet AJ, Visentin M; QPM Group.

J Pain Symptom Manage. 2014 Feb;47(2):298-306. doi: 10.1016/j.jpainsymman.2013.03.018. Epub 2013 Jul 12.

PMID:
23856096
27.

Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells.

Davinelli S, Sapere N, Visentin M, Zella D, Scapagnini G.

Immun Ageing. 2013 Jul 11;10(1):28. doi: 10.1186/1742-4933-10-28.

28.

Inhibition of the proton-coupled folate transporter (PCFT-SLC46A1) by bicarbonate and other anions.

Zhao R, Visentin M, Suadicani SO, Goldman ID.

Mol Pharmacol. 2013 Jul;84(1):95-103. doi: 10.1124/mol.113.085605. Epub 2013 Apr 22.

29.

Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.

Del Ross T, Ruffatti A, Visentin MS, Tonello M, Calligaro A, Favaro M, Hoxha A, Punzi L.

J Rheumatol. 2013 Apr;40(4):425-9. doi: 10.3899/jrheum.120576. Epub 2013 Feb 15.

PMID:
23418380
30.

Polymorphic thymidylate synthase gene impacts on overall survival of patients with epithelial ovarian cancer after platinum-based chemotherapy.

Biason P, Visentin M, Talamini R, Stopar A, Giorda G, Lucia E, Campagnutta E, Toffoli G.

Pharmacogenomics. 2012 Nov;13(14):1609-19. doi: 10.2217/pgs.12.136.

PMID:
23148637
31.

Parotid, breast, and fascial involvement in a patient who fulfilled the ACR criteria for Churg-Strauss syndrome.

Visentin MS, Salmaso R, Modesti V, Ometto F, Ruffatti A, Punzi L, Doria A.

Scand J Rheumatol. 2012 Aug;41(4):319-21. doi: 10.3109/03009742.2012.672593. No abstract available.

PMID:
22804574
32.

Interpretation of laboratory data and need for reference laboratories.

Pengo V, Denas G, Banzato A, Bison E, Bracco A, Visentin MS, Hoxha A, Ruffatti A.

Lupus. 2012 Jun;21(7):732-3. doi: 10.1177/0961203312437271.

PMID:
22635216
33.
34.

The antifolates.

Visentin M, Zhao R, Goldman ID.

Hematol Oncol Clin North Am. 2012 Jun;26(3):629-48, ix. doi: 10.1016/j.hoc.2012.02.002. Review.

35.

Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1).

Visentin M, Chang MH, Romero MF, Zhao R, Goldman ID.

Mol Pharmacol. 2012 Feb;81(2):134-42. doi: 10.1124/mol.111.074823. Epub 2011 Oct 21.

36.

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.

Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A.

Rheumatology (Oxford). 2011 Sep;50(9):1684-9. doi: 10.1093/rheumatology/ker139. Epub 2011 Jun 7.

PMID:
21652586
37.

Mechanisms of membrane transport of folates into cells and across epithelia.

Zhao R, Diop-Bove N, Visentin M, Goldman ID.

Annu Rev Nutr. 2011 Aug 21;31:177-201. doi: 10.1146/annurev-nutr-072610-145133. Review.

38.

[Patients' satisfaction with pain management: the italian version of the Patient Outcome Questionnaire of the American Pain Society].

Ferrari R, Novello C, Catania G, Visentin M.

Recenti Prog Med. 2010 Jul-Aug;101(7-8):283-8. Italian.

PMID:
20842954
39.

Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agents.

Visentin M, Biason P, Toffoli G.

Pharmacol Ther. 2010 Oct;128(1):82-90. doi: 10.1016/j.pharmthera.2010.05.005. Epub 2010 Jun 11. Review.

PMID:
20542058
40.

Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.

Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso ML, Biason P, Visentin M, Nitti D, Toffoli G.

Pharmacogenomics J. 2011 Jun;11(3):214-26. doi: 10.1038/tpj.2010.25. Epub 2010 Apr 6.

PMID:
20368715
41.

[The Italian version of NOPPAIN Scale: validation during education].

Novello C, Ferrari R, Scacco C, Visentin M.

Assist Inferm Ric. 2009 Oct-Dec;28(4):198-205. Italian.

PMID:
20222521
42.

Pain assessment in non-communicative patients: the Italian version of the Non-Communicative Patient's Pain Assessment Instrument (NOPPAIN).

Ferrari R, Martini M, Mondini S, Novello C, Palomba D, Scacco C, Toffolon M, Valerio G, Vescovo G, Visentin M.

Aging Clin Exp Res. 2009 Aug-Oct;21(4-5):298-306.

PMID:
19959918
43.

Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised scleroderma.

Howell KJ, Lavorato A, Visentin MT, Smith RE, Schaefer G, Jones CD, Weibel L, Denton CP, Harper JI, Woo P.

Skin Res Technol. 2009 Aug;15(3):346-56. doi: 10.1111/j.1600-0846.2009.00371.x.

PMID:
19624432
44.

Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.

Beraudi A, Stea S, Cremonini S, Visentin M, Toni A.

Artif Organs. 2009 Jul;33(7):538-43. doi: 10.1111/j.1525-1594.2009.00736.x.

PMID:
19566730
45.

Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells.

Visentin M, Simula MP, Sartor F, Petrucco A, De Re V, Toffoli G.

Int J Oncol. 2009 May;34(5):1281-9.

PMID:
19360340
46.

Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis.

Majone F, Olivieri S, Cozzi F, Montaldi A, Tonello M, Visentin MS, Ciprian L, Ruffatti A.

Rheumatol Int. 2009 Jun;29(8):891-5. doi: 10.1007/s00296-008-0799-x. Epub 2008 Dec 3.

PMID:
19050892
47.

Laser Doppler flowmetry for assessing localized scleroderma in children.

Weibel L, Howell KJ, Visentin MT, Rudiger A, Denton CP, Zulian F, Woo P, Harper JI.

Arthritis Rheum. 2007 Oct;56(10):3489-95.

48.

A questionnaire to evaluate the knowledge and attitudes of health care providers on pain.

Zanolin ME, Visentin M, Trentin L, Saiani L, Brugnolli A, Grassi M.

J Pain Symptom Manage. 2007 Jun;33(6):727-36.

PMID:
17531913
49.

MicroCT examination of human bone specimens: effects of polymethylmethacrylate embedding on structural parameters.

Perilli E, Baruffaldi F, Visentin M, Bordini B, Traina F, Cappello A, Viceconti M.

J Microsc. 2007 Feb;225(Pt 2):192-200.

50.

Early diagnosis of ceramic liner fracture. Guidelines based on a twelve-year clinical experience.

Toni A, Traina F, Stea S, Sudanese A, Visentin M, Bordini B, Squarzoni S.

J Bone Joint Surg Am. 2006 Dec;88 Suppl 4:55-63. No abstract available.

PMID:
17142435

Supplemental Content

Loading ...
Support Center